読み込み中
HKSEHealthcareMedical - Care Facilities
最新データ
HK$0.705
+HK$0.005 · +0.71%
Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
最新データ
HK$0.705
+HK$0.005 · +0.71%
日中の時刻はHKTです。市場データは遅延する場合があります。
Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
日中レンジ
現在 HK$0.705
52週レンジ
現在 HK$0.705
日中の時刻はHKTです。市場データは遅延する場合があります。
Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
日中レンジ
現在 HK$0.705
52週レンジ
現在 HK$0.705
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（CNY） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 4.48億 CNY | 3.88億 CNY | 5.39億 CNY | 4.72億 CNY | 4.71億 CNY |
| 売上原価 | 4.17億 CNY | 4.56億 CNY | 6.04億 CNY | 7.47億 CNY | 6.6億 CNY |
| 粗利益 | 3112.31万 CNY | −6724.8万 CNY | −6508.9万 CNY | −1.97億 CNY | −9275.54万 CNY |
| 研究開発 | 2744.29万 CNY | 3118.4万 CNY | 3644.3万 CNY | 4131.6万 CNY | 4038.1万 CNY |
| 販売・一般管理 | 1.87億 CNY | 2.59億 CNY | 2.53億 CNY | 2.74億 CNY | 1.03億 CNY |
| 営業費用 | 2.63億 CNY | 3.3億 CNY | 2.89億 CNY | 3.59億 CNY | 3.76億 CNY |
| 受取利息 | 65.85万 CNY | 73.3万 CNY | 728.1万 CNY | 778.6万 CNY | 546.7万 CNY |
| 支払利息 | 1.2億 CNY | 1.09億 CNY | 1.08億 CNY | 2.74億 CNY | 4.35億 CNY |
| 減価償却費と償却費 | 1.53億 CNY | 1.14億 CNY | 1.52億 CNY | 1.48億 CNY | 1.14億 CNY |
| 営業利益 | −2.32億 CNY | −3.71億 CNY | −3.54億 CNY | −4.78億 CNY | −3.93億 CNY |
| 純利益 | −2.5億 CNY | −4.43億 CNY | −3.73億 CNY | −5.41億 CNY | −8.17億 CNY |
会社概要が更新されました 2026年10月11日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
